These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 38816795

  • 1. Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013-2021.
    Gonzalez J, Dave CV.
    BMC Cardiovasc Disord; 2024 May 30; 24(1):285. PubMed ID: 38816795
    [Abstract] [Full Text] [Related]

  • 2. Qualitative evaluation to understand barriers and facilitators to prescribing angiotensin receptor-neprilysin inhibitors (ARNi) and sodium-glucose cotransporter inhibitors (SGLT2i) in patients with heart failure with reduced ejection fraction (HFrEF).
    Pradhan AM, Lussier ME, Nguyen M, Voyce SJ, Wright EA.
    J Am Pharm Assoc (2003); 2024 May 30; 64(6):102224. PubMed ID: 39209218
    [Abstract] [Full Text] [Related]

  • 3. Trends in utilization patterns of newer glucose-lowering drugs in US adults with type 2 diabetes and a history of coronary heart disease or heart failure: 2005-2019.
    Alshehri A, Guan D, Li P, Zhang Y, Ghayee HK, Jiao T, Shao H.
    Prim Care Diabetes; 2024 Oct 30; 18(5):561-563. PubMed ID: 39095227
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924
    [Abstract] [Full Text] [Related]

  • 5. Increased risk of adverse events among patients with vs. without systemic autoimmune rheumatic disease prescribed sodium-glucose cotransporter 2 inhibitors: a retrospective cohort study.
    Oakes EG, Ellrodt J, Guan H, Yee J, Choi MY, Costenbader KH.
    Clin Rheumatol; 2024 Dec 01; 43(12):3839-3847. PubMed ID: 39448504
    [Abstract] [Full Text] [Related]

  • 6. SGLT2 inhibitors across the spectrum of chronic kidney disease: a narrative review.
    Sloan L.
    Postgrad Med; 2024 Nov 01; 136(8):801-809. PubMed ID: 39434704
    [Abstract] [Full Text] [Related]

  • 7. The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.
    Loria F, Mone P, Rispoli A, Di Fonzo R, Masarone D, Mancusi C, Correale M, Vitullo A, Granatiero M, Mazzeo P, Mercurio V, Fiore F, Di Sarro E, Falco L, Izzo C, Campanile A, Virtuoso N, Stabile E, Bonanno S, Dattilo G, Tocchetti CG, Santulli G, Vecchione C, Ciccarelli M, Visco V.
    Cardiovasc Diabetol; 2024 Nov 22; 23(1):423. PubMed ID: 39578847
    [Abstract] [Full Text] [Related]

  • 8. Tobacco Product Use and Associated Factors Among Middle and High School Students - National Youth Tobacco Survey, United States, 2021.
    Gentzke AS, Wang TW, Cornelius M, Park-Lee E, Ren C, Sawdey MD, Cullen KA, Loretan C, Jamal A, Homa DM.
    MMWR Surveill Summ; 2022 Mar 11; 71(5):1-29. PubMed ID: 35271557
    [Abstract] [Full Text] [Related]

  • 9. Albuminuria-based stratification of end-stage kidney disease progression and mortality with sodium-glucose cotransporter 2 inhibitors (SGLT2i): A retrospective cohort study in type 2 diabetes and chronic kidney disease.
    Chang TJ, Lee YC, Wu LC, Chang CH.
    Pharmacotherapy; 2024 Nov 11; 44(11):828-840. PubMed ID: 39382257
    [Abstract] [Full Text] [Related]

  • 10. A Small Number of Surgeons Perform the Large Majority of Uncommon Nerve Decompression Procedures.
    Brinkman N, Ramtin S, Ring D, Adams JE.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2182-2190. PubMed ID: 38905446
    [Abstract] [Full Text] [Related]

  • 11. Role of NLRP3 Inflammasome in Heart Failure Patients Undergoing Cardiac Surgery as a Potential Determinant of Postoperative Atrial Fibrillation and Remodeling: Is SGLT2 Cotransporter Inhibition an Alternative for Cardioprotection?
    Castillo RL, Farías J, Sandoval C, González-Candia A, Figueroa E, Quezada M, Cruz G, Llanos P, Jorquera G, Kostin S, Carrasco R.
    Antioxidants (Basel); 2024 Nov 14; 13(11):. PubMed ID: 39594530
    [Abstract] [Full Text] [Related]

  • 12. Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.
    Mihaylova B, Wu R, Zhou J, Williams C, Schlackow I, Emberson J, Reith C, Keech A, Robson J, Parnell R, Armitage J, Gray A, Simes J, Baigent C.
    Health Technol Assess; 2024 Dec 14; 28(79):1-134. PubMed ID: 39644281
    [Abstract] [Full Text] [Related]

  • 13. Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes.
    Aggarwal S, Moir J, Hyman MJ, Kaufmann GT, Flores A, Hariprasad SM, Skondra D.
    JAMA Ophthalmol; 2024 Jan 01; 142(1):53-57. PubMed ID: 38019527
    [Abstract] [Full Text] [Related]

  • 14.
    Kirtsoglou E, Simpson B, Salisbury L, Baraitser L.
    ; 2020 Jan 01. PubMed ID: 36137063
    [Abstract] [Full Text] [Related]

  • 15. Mobile apps to reduce depressive symptoms and alcohol use in youth: A systematic review and meta-analysis: A systematic review.
    Magwood O, Saad A, Ranger D, Volpini K, Rukikamirera F, Haridas R, Sayfi S, Alexander J, Tan Y, Pottie K.
    Campbell Syst Rev; 2024 Jun 01; 20(2):e1398. PubMed ID: 38680950
    [Abstract] [Full Text] [Related]

  • 16. Cardiorespiratory Fitness in Adolescence and Risk of Type 2 Diabetes in Late Adulthood: A Nationwide Sibling-Controlled Cohort Study.
    Ballin M, Ahlqvist VH, Berglind D, Brunström M, Angel HA, Henriksson P, Neovius M, Ortega FB, Nordström A, Nordström P.
    medRxiv; 2024 Nov 28. PubMed ID: 39649593
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin receptor neprilysin inhibitor in chronic heart failure and comorbidity management: Indian consensus statement.
    Mittal S, Harikrishnan S, Gupta A, Bansal S, Koshy GA, Mohanan PP, Bhattacharya D, Kerkar P, Swamy A, Aggarwal V, Srivastava S, Mahajan A, Mehta A, Sharma K, Shetty S.
    Ther Adv Cardiovasc Dis; 2024 Nov 28; 18():17539447241301959. PubMed ID: 39641242
    [Abstract] [Full Text] [Related]

  • 18. Trends and hospital practice variation for analgesia for children with sickle cell disease with vaso-occlusive pain episodes: An 11-year analysis.
    Eltorki M, Hall M, Ramgopal S, Chaudhari PP, Badaki-Makun O, Rees CA, Bergmann KR, Shapiro DJ, Gonzalez F, Phamduy T, Neuman MI.
    Am J Emerg Med; 2024 Dec 28; 86():129-134. PubMed ID: 39427500
    [Abstract] [Full Text] [Related]

  • 19. Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis.
    Yan Q, Chen X, Yu C, Yin Y.
    BMC Cardiovasc Disord; 2024 Nov 22; 24(1):663. PubMed ID: 39578752
    [Abstract] [Full Text] [Related]

  • 20. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R, Hill S.
    Cochrane Database Syst Rev; 2019 Oct 23; 10(10):ED000141. PubMed ID: 31643081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.